- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
191
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
191 companies
Diaceutics
Market Cap: UK£135.4m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.60
7D
10.7%
1Y
19.9%
Dar Al Dawa Development and Investment
Market Cap: د.أ39.9m
Dar Al Dawa Development and Investment Co.
DADI
د.أ1.13
7D
-2.6%
1Y
-9.6%
Actinogen Medical
Market Cap: AU$98.4m
A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.
ACW
AU$0.031
7D
-8.8%
1Y
24.0%
Medicure
Market Cap: CA$11.5m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.10
7D
0%
1Y
8.9%
Coherus Oncology
Market Cap: US$181.3m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.58
7D
17.0%
1Y
59.5%
Zura Bio
Market Cap: US$133.9m
A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.
ZURA
US$2.29
7D
20.5%
1Y
-41.4%
Erasca
Market Cap: US$502.1m
A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
ERAS
US$1.91
7D
14.4%
1Y
-30.3%
IDL Diagnostics
Market Cap: SEK 92.1m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.40
7D
-3.1%
1Y
-23.8%
Metagenomi
Market Cap: US$81.8m
A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.
MGX
US$2.09
7D
11.2%
1Y
0%
Fuan Pharmaceutical (Group)
Market Cap: CN¥5.1b
Research and develops, produces, and sells chemical drugs in the People's Republic of China.
300194
CN¥4.29
7D
-5.5%
1Y
5.9%
Genelux
Market Cap: US$162.1m
A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
GNLX
US$4.37
7D
11.8%
1Y
120.7%
Heidelberg Pharma
Market Cap: €160.8m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.
HPHA
€3.45
7D
-2.0%
1Y
49.4%
MediPharm Labs
Market Cap: CA$29.5m
Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
LABS
CA$0.07
7D
0%
1Y
0%
Neumora Therapeutics
Market Cap: US$309.3m
A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.
NMRA
US$1.83
7D
26.2%
1Y
-85.7%
Rallybio
Market Cap: US$24.5m
A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
RLYB
US$0.59
7D
3.9%
1Y
-46.3%
Uni-Bio Science Group
Market Cap: HK$877.8m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.15
7D
-3.3%
1Y
77.1%
Cumberland Pharmaceuticals
Market Cap: US$44.6m
A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.
CPIX
US$3.06
7D
-5.3%
1Y
146.8%
Delivra Health Brands
Market Cap: CA$5.9m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.20
7D
7.9%
1Y
2.5%
Pliant Therapeutics
Market Cap: US$89.6m
A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.
PLRX
US$1.46
7D
0%
1Y
-87.1%
Lisata Therapeutics
Market Cap: US$20.1m
A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
LSTA
US$2.35
7D
3.1%
1Y
-17.8%
Viva Biotech Holdings
Market Cap: HK$5.4b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$2.56
7D
2.0%
1Y
265.7%
ABIONYX Pharma
Market Cap: €135.4m
A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.
ABNX
€3.91
7D
1.7%
1Y
202.2%
Relmada Therapeutics
Market Cap: US$55.4m
Operates as a clinical-stage biotechnology company in the United States.
RLMD
US$1.65
7D
9.3%
1Y
-51.2%
AN2 Therapeutics
Market Cap: US$35.3m
A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.
ANTX
US$1.28
7D
-1.2%
1Y
21.4%
Caribou Biosciences
Market Cap: US$173.2m
A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.
CRBU
US$2.13
7D
23.8%
1Y
12.7%
Atea Pharmaceuticals
Market Cap: US$230.1m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.
AVIR
US$2.90
7D
-0.3%
1Y
-15.5%
Nuvation Bio
Market Cap: US$1.1b
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$3.24
7D
-0.6%
1Y
35.6%
Veru
Market Cap: US$49.4m
A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).
VERU
US$3.45
7D
0.9%
1Y
-55.6%
Novakand Pharma
Market Cap: SEK 32.5m
Develops drugs for inflammatory diseases and cancer in Sweden and internationally.
NOVKAN
SEK 0.27
7D
-71.2%
1Y
-86.6%
Invex Therapeutics
Market Cap: AU$12.0m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.16
7D
23.1%
1Y
116.2%
RAMM Pharma
Market Cap: CA$1.8m
Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.015
7D
50.0%
1Y
n/a
BioLight Life Sciences
Market Cap: ₪19.0m
An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.
BOLT
₪4.06
7D
0.2%
1Y
-3.9%
Steep Hill
Market Cap: CA$970.7k
Does not have significant operations.
STPH
CA$0.06
7D
0%
1Y
140.0%
Zenith Healthcare
Market Cap: ₹226.2m
Manufactures and markets pharmaceutical formulations in India.
530665
₹4.22
7D
-2.1%
1Y
-23.0%
Barinthus Biotherapeutics
Market Cap: US$42.8m
A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.
BRNS
US$1.18
7D
10.2%
1Y
-1.8%
Cassava Sciences
Market Cap: US$164.7m
A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
SAVA
US$3.26
7D
56.7%
1Y
-89.3%